Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuaki Mamesaya

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Respiratory Investigation|April 22, 2017
Percutaneous endoscopic gastrostomy for aspiration pneumonia: A 10-year single-center experienceHiromi Tomioka, Shyuji Yamashita, Nobuaki Mamesaya, et al.
BMC Cancer|July 8, 2017
ALK-rearranged lung squamous cell carcinoma responding to alectinib: a case report and review of the literatureNobuaki Mamesaya, Kazuhisa Nakashima, Tateaki Naito, et al.
BMJ Open Respiratory Research|March 3, 2016
Combined pulmonary fibrosis and emphysema: effect of pulmonary rehabilitation in comparison with chronic obstructive pulmonary diseaseHiromi Tomioka, Nobuaki Mamesaya, Shyuji Yamashita, et al.
Investigational New Drugs|September 8, 2016
Osimertinib-induced interstitial lung disease after treatment with anti-PD1 antibodyNobuaki Mamesaya, Hirotsugu Kenmotsu, Mineo Katsumata, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|December 4, 2012
[Three autopsy cases of chronic necrotizing pulmonary aspergillosis]Nobuaki Mamesaya, Hiromi Tomioka, Toshihiko Kaneda, et al.
The Journal of Liquid Biopsy|December 25, 2025
Cerebrospinal fluid ctDNA clarifies clonal divergence: leptomeningeal flare of <i>EGFR</i>-mutant disease after switch to selpercatinib for acquired <i>RET</i> fusionKei Kunimasa, Motohiro Tamiya, Takako Inoue, et al.
Clinical Lung Cancer|July 5, 2023
Continuous vs. Fixed 2-year Duration Immune Checkpoint Inhibitor Treatment of Patients With Non-Small Cell Lung Cancer: A Single Institution Database AnalysisHaruki Kobayashi, Kazushige Wakuda, Tateaki Naito, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2022
Phase 1b study of ramucirumab in combination with irinotecan plus cisplatin in chemo-naïve patients with extensive-stage small-cell lung cancerHirotsugu Kenmotsu, Keita Mori, Risa Mizuno, et al.
International Journal of Clinical Oncology|July 5, 2025
Phase II study of afatinib for advanced non-small cell lung cancer with uncommon epidermal growth factor receptor mutations, including compound mutations detected by next-generation sequencingNobuaki Mamesaya, Keita Mori, Haruki Kobayashi, et al.
Radiation Oncology (London, England)|March 18, 2021
Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalitiesHaruki Kobayashi, Kazushige Wakuda, Tateaki Naito, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Respiratory Investigation|April 22, 2017
Percutaneous endoscopic gastrostomy for aspiration pneumonia: A 10-year single-center experienceHiromi Tomioka, Shyuji Yamashita, Nobuaki Mamesaya, et al.
BMC Cancer|July 8, 2017
ALK-rearranged lung squamous cell carcinoma responding to alectinib: a case report and review of the literatureNobuaki Mamesaya, Kazuhisa Nakashima, Tateaki Naito, et al.
BMJ Open Respiratory Research|March 3, 2016
Combined pulmonary fibrosis and emphysema: effect of pulmonary rehabilitation in comparison with chronic obstructive pulmonary diseaseHiromi Tomioka, Nobuaki Mamesaya, Shyuji Yamashita, et al.
Investigational New Drugs|September 8, 2016
Osimertinib-induced interstitial lung disease after treatment with anti-PD1 antibodyNobuaki Mamesaya, Hirotsugu Kenmotsu, Mineo Katsumata, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|December 4, 2012
[Three autopsy cases of chronic necrotizing pulmonary aspergillosis]Nobuaki Mamesaya, Hiromi Tomioka, Toshihiko Kaneda, et al.
The Journal of Liquid Biopsy|December 25, 2025
Cerebrospinal fluid ctDNA clarifies clonal divergence: leptomeningeal flare of <i>EGFR</i>-mutant disease after switch to selpercatinib for acquired <i>RET</i> fusionKei Kunimasa, Motohiro Tamiya, Takako Inoue, et al.
Clinical Lung Cancer|July 5, 2023
Continuous vs. Fixed 2-year Duration Immune Checkpoint Inhibitor Treatment of Patients With Non-Small Cell Lung Cancer: A Single Institution Database AnalysisHaruki Kobayashi, Kazushige Wakuda, Tateaki Naito, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2022
Phase 1b study of ramucirumab in combination with irinotecan plus cisplatin in chemo-naïve patients with extensive-stage small-cell lung cancerHirotsugu Kenmotsu, Keita Mori, Risa Mizuno, et al.
International Journal of Clinical Oncology|July 5, 2025
Phase II study of afatinib for advanced non-small cell lung cancer with uncommon epidermal growth factor receptor mutations, including compound mutations detected by next-generation sequencingNobuaki Mamesaya, Keita Mori, Haruki Kobayashi, et al.
Radiation Oncology (London, England)|March 18, 2021
Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalitiesHaruki Kobayashi, Kazushige Wakuda, Tateaki Naito, et al.
Pageof 8